Type 1 Papillary Renal Cell Carcinoma Active Not Recruiting Phase 2 Trials for Ipilimumab (DB06186)

Also known as: Papillary Renal Cell Carcinoma Type 1

IndicationStatusPhase
DBCOND0029157 (Type 1 Papillary Renal Cell Carcinoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03177239Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602)Treatment